A股午評:滬指漲0.11%收復3400點 創新藥、固態電池概念領漲
A股主要指數漲跌不一,截至午盤,滬指漲0.11%報3403.52點,深成指跌0.23%,創業板指跌0.36%,北證50指數跌0.12%。全市場半日成交額8082億元,較上日縮量304億元,超3300只個股飄綠。盤面上,創新藥概念股持續活躍,哈三聯、昂利康、衆生藥業漲停,中辦、國辦印發《關於進一步保障和改善民生 着力解決羣衆急難愁盼的意見》提出,完善基本醫療保險藥品目錄調整機制,制定出臺商業健康保險創新藥品目錄等;固態電池裝車漸行漸近,相關概念股走強,金銀河、龍蟠科技、道明光學漲停;“蘇超”概念熱度持續,共創草坪7連板,康力源、粵傳媒漲停。另外,軍工裝備板塊跌幅靠前,捷強裝備跌超13%,邁信林跌近10%;人形機器人概念走弱,斯菱股份、宏潤建設跌約7%。個股方面,中科曙光漲停,海光信息漲超4%,海光信息擬換股吸收合併中科曙光。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.